Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-18,887
Closed -$4.96M 485
2022
Q4
$4.96M Buy
18,887
+11,195
+146% +$3M 0.84% 9
2022
Q3
$1.73M Sell
7,692
-4,750
-38% -$1.15M 0.32% 87
2022
Q2
$3.03M Buy
+12,442
New +$3.05M 0.71% 26
2021
Q4
Sell
-9,115
Closed -$1.94M 409
2021
Q3
$1.94M Buy
+9,115
New +$2.1M 0.53% 43
2021
Q1
Sell
-10,297
Closed -$2.37M 382
2020
Q4
$2.37M Buy
+10,297
New +$2.37M 0.85% 20
2020
Q2
Sell
-65
Closed -$13K 286
2020
Q1
$13K Buy
+65
New +$14.2K 0.03% 355
2019
Q4
Sell
-1,298
Closed -$251K 520
2019
Q3
$251K Buy
+1,298
New +$249K 0.72% 15

Other funds holding AMGN

Pearl River Capital's AMGN Position: Q1 2023 in Review

Pearl River Capital sold out of Amgen (AMGN) in Q1 2023, closing a stake of 18,887 shares — an estimated $4.96M sold.

Pearl River Capital first reported a position in AMGN in Q3 2019 and held it in 7 quarters. The position peaked at $4.96M in Q4 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Pearl River Capital reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Pearl River Capital sold 18,887 Amgen shares in Q1 2023, an estimated $4.96M.
  • Pearl River Capital first reported a position in Amgen in Q3 2019 and held it in 7 quarters.
  • Pearl River Capital's Amgen position peaked at $4.96M in Q4 2022.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Pearl River Capital's 13F filing for Q1 2023, filed 12 May 2023.